Common Stock	6 Months Ended
Jun. 30, 2020
Common Stock [Abstract]
Common Stock	13. Common Stock Stock Incentive Plans On January 21, 2020, the compensation committee of BBX Capital’s Board of Directors granted awards of 488,503 restricted shares of BBX Capital’s Class A Common Stock to its executive officers under the BBX Capital Corporation 2014 Incentive Plan. The aggregate grant date fair value of the awards was $10.2 million, and the shares vest ratably in annual installments of approximately 122,125 shares over four periods beginning on October 1, 2020. As of June 30, 2020, BBX Capital had 488,503 and 528,484 unvested restricted shares of its Class A and Class B Common Stock outstanding, respectively, with total unrecognized compensation costs of $19.8 million. Earnings per Share During the three and six months ended June 30, 2020, 1,016,981 shares of unvested restricted stock awards were not included in the computation of diluted earnings per share as the shares were antidilutive due to the Company’s recognition of a loss for such periods. During the three and six months ended June 30, 2019, 1,022,103 shares of unvested restricted stock awards were not included in the computation of diluted earnings per share as the shares were antidilutive due to the Company’s recognition of a loss for such periods.

Common Stock

6 Months Ended

Jun. 30, 2020

13. Common Stock

Stock Incentive Plans

On January 21, 2020, the compensation committee of BBX Capital’s Board of Directors granted awards of 488,503 restricted shares of BBX Capital’s Class A Common Stock to its executive officers under the BBX Capital Corporation 2014 Incentive Plan. The aggregate grant date fair value of the awards was $10.2 million, and the shares vest ratably in annual installments of approximately 122,125 shares over four periods beginning on October 1, 2020.

As of June 30, 2020, BBX Capital had 488,503 and 528,484 unvested restricted shares of its Class A and Class B Common Stock outstanding, respectively, with total unrecognized compensation costs of $19.8 million.

Earnings per Share

During the three and six months ended June 30, 2020, 1,016,981 shares of unvested restricted stock awards were not included in the computation of diluted earnings per share as the shares were antidilutive due to the Company’s recognition of a loss for such periods. During the three and six months ended June 30, 2019, 1,022,103 shares of unvested restricted stock awards were not included in the computation of diluted earnings per share as the shares were antidilutive due to the Company’s recognition of a loss for such periods.